Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 18, 2022 - Issue 1
Submit an article Journal homepage
1,937
Views
9
CrossRef citations to date
0
Altmetric
Editorial

Positioning the new drugs for migraine

Silvia Benemeia Headache Centre and Clinical Pharmacology Unit, Careggi University Hospital, Florence, ItalyORCID Iconhttps://orcid.org/0000-0001-6316-430XView further author information
ORCID Icon,
Enrico Bentivegnab Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy;c Regional Referral Hedache Center, Sant’Andrea University Hospital, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-6655-9905View further author information
ORCID Icon &
Paolo Martellettib Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy;c Regional Referral Hedache Center, Sant’Andrea University Hospital, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6556-4128View further author information
ORCID Icon
Pages 1-3 | Received 05 Jan 2022, Accepted 01 Mar 2022, Published online: 09 Mar 2022

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hongsheng Chen & Wenqing Luo. (2022) Efficacy and safety of eptinezumab 300mg versus 100mg for migraine patients: a meta-analysis of randomized controlled studies. International Journal of Neuroscience 0:0, pages 1-6.
Read now

Articles from other publishers (8)

Enrico Bentivegna, Dilara Onan & Paolo Martelletti. (2023) Unmet Needs in Preventive Treatment of Migraine. Neurology and Therapy 12:2, pages 337-342.
Crossref
Devahuti R. Chaliha, Mauro Vaccarezza, Emily Corti, Ryusuke Takechi, Satvinder S. Dhaliwal, Peter Drummond, Eric Visser, Fred K. Chen, Jason Charng, Virginie Lam & John C.L. Mamo. (2023) L-arginine and aged garlic extract for the prevention of migraine: a study protocol for a randomised, double-blind, placebo-controlled, phase-II trial (LARGE trial). BMC Neurology 23:1.
Crossref
Robert P. Cowan, Michael J. Marmura, Hans-Christoph Diener, Amaal J. Starling, Jack Schim, Joe Hirman, Thomas Brevig & Roger Cady. (2022) Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study. The Journal of Headache and Pain 23:1.
Crossref
Roger Cady, Richard B. Lipton, Dawn C. Buse, Mette Krog Josiassen, Annika Lindsten & Anders Ettrup. (2022) Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study. The Journal of Headache and Pain 23:1.
Crossref
Dilara Onan, William Wells-Gatnik & Paolo Martelletti. (2022) Reaching the Nadir of Medication Overuse in Chronic Migraine. International Journal of Environmental Research and Public Health 19:22, pages 14696.
Crossref
Mengya Wang, Joseph O. Tutt, Nicholas O. Dorricott, Krystal L. Parker, Andrew F. Russo & Levi P. Sowers. (2022) Involvement of the cerebellum in migraine. Frontiers in Systems Neuroscience 16.
Crossref
Fidel Dominique Festin Ambat, Enrico Bentivegna & Paolo Martelletti. (2022) Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine. BioDrugs 36:3, pages 337-339.
Crossref
Adriana Della Pietra, Juha Savinainen & Rashid Giniatullin. (2022) Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain. International Journal of Molecular Sciences 23:8, pages 4407.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.